Recombinant Anaplastic Lymphoma Kinase (ALK)

CD246; TFG/ALK; Ki1; Anaplastic Lymphoma Receptor Tyrosine Kinase

  • Recombinant Anaplastic Lymphoma Kinase (ALK) Packages (Simulation)
  • Recombinant Anaplastic Lymphoma Kinase (ALK) Packages (Simulation)
  • RPA870Hu01.jpg SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

SEQUENCE of the Recombinant Anaplastic Lymphoma Kinase (ALK)

USAGE of the Recombinant Anaplastic Lymphoma Kinase (ALK)

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE of the Recombinant Anaplastic Lymphoma Kinase (ALK)

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY of the Recombinant Anaplastic Lymphoma Kinase (ALK)

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPA870Hu01 Recombinant Anaplastic Lymphoma Kinase (ALK) Positive Control; Immunogen; SDS-PAGE; WB.
PAA870Hu01 Polyclonal Antibody to Anaplastic Lymphoma Kinase (ALK) WB; IHC; ICC; IP.
GUESTBOOK